(Q42491437)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16505950%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

A phase I trial of the bombesin/gastrin-releasing peptide (BN/GRP) antagonist RC3095 in patients with advanced solid malignancies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16505950%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

main subject

phase I clinical trial

0 references

author

Gilberto Schwartsmann

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16505950%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Gilberto de Nucci

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16505950%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Paula Pohlmann

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16505950%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

L P DiLeone

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16505950%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

M Horowitz

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16505950%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

D Schunemann

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16505950%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

A Cancella

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16505950%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

A S Pereira

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16505950%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

M Richter

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16505950%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

F Souza

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16505950%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

A Brondani da Rocha

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16505950%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

F H Souza

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16505950%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

1 September 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16505950%20AND%20SRC:MED&resulttype=core&format=json

Investigational New Drugs

17 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16505950%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16505950%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16505950%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

403-412

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16505950%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10637-006-6886-5

17 January 2020

exact match

0 references

cites work

Bombesin stimulates proliferation of human breast cancer cells in culture

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10637-006-6886-5

Quantification of the bombesin/gastrin releasing peptide antagonist RC-3095 by liquid chromatography-tandem mass spectrometry.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10637-006-6886-5

Inhibitory effects of antagonists of bombesin/gastrin releasing peptide (GRP) and somatostatin analog (RC-160) on growth of HT-29 human colon cancers in nude mice

21 January 2018

1 reference

12 December 2020

Inhibition of growth of OV-1063 human epithelial ovarian cancers and c- jun and c- fos oncogene expression by bombesin antagonists

1 reference

12 December 2020

Inhibitory effect of bombesin receptor antagonist RC-3095 on the growth of human pancreatic cancer cells in vivo and in vitro

1 reference

12 December 2020

Selective stimulation of small cell lung cancer clonal growth by bombesin and gastrin-releasing peptide

1 reference

12 December 2020

Bombesin/gastrin-releasing peptide antagonists RC-3095 and RC-3940-II inhibit tumor growth and decrease the levels and mRNA expression of epidermal growth factor receptors in H-69 small cell lung carcinoma

1 reference

12 December 2020

Stimulation by bombesin and inhibition by bombesin/gastrin-releasing peptide antagonist RC-3095 of growth of human breast cancer cell lines

1 reference

12 December 2020

Inhibition of growth of MKN45 human gastric-carcinoma xenografts in nude mice by treatment with bombesin/gastrin-releasing-peptide antagonist (RC-3095) and somatostatin analogue RC-160.

1 reference

12 December 2020

Gastrin-releasing peptide: in vivo and in vitro growth effects on an acinar pancreatic carcinoma

1 reference

12 December 2020

RC-3095, a bombesin/gastrin-releasing peptide receptor antagonist, impairs aversive but not recognition memory in rats.

1 reference

12 December 2020

Potent bombesin antagonists with C-terminal Leu-psi(CH2-N)-Tac-NH2 or its derivatives

1 reference

12 December 2020

Inhibitory effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 on the growth of the androgen-independent Dunning R-3327-AT-1 rat prostate cancer.

1 reference

12 December 2020

Bombesin antagonists inhibit proangiogenic factors in human experimental breast cancers.

1 reference

12 December 2020

Bombesin stimulates growth of human prostatic cancer cells in vitro

1 reference

12 December 2020

High potency of a new bombesin antagonist (RC-3095) in inhibiting serum gastrin levels; comparison of different routes of administration

1 reference

12 December 2020

Inhibitory effect of bombesin/gastrin-releasing peptide antagonist RC-3095 and luteinizing hormone-releasing hormone antagonist SB-75 on the growth of MCF-7 MIII human breast cancer xenografts in athymic nude mice

1 reference

12 December 2020

Bombesin antagonists inhibit in vitro and in vivo growth of human gastric cancer and binding of bombesin to its receptors

1 reference

12 December 2020

Elevation of serum pro-gastrin-releasing peptide in patients with medullary thyroid carcinoma and small cell lung carcinoma

1 reference

12 December 2020

Neuropeptides and anxiety disorders: bombesin receptors as novel therapeutic targets.

1 reference

12 December 2020

Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer

1 reference

12 December 2020

Inhibition of growth of human malignant glioblastoma in nude mice by antagonists of bombesin/gastrin-releasing peptide

1 reference

12 December 2020

Pseudononapeptide bombesin antagonists containing C-terminal Trp or Tpi

1 reference

12 December 2020

Synergistic effects of bombesin and epidermal growth factor on cancers

1 reference

12 December 2020

Bombesin/gastrin-releasing peptide receptors in the basolateral amygdala regulate memory consolidation.

1 reference

12 December 2020

Growth inhibition of estrogen-dependent and estrogen-independent MXT mammary cancers in mice by the bombesin and gastrin-releasing peptide antagonist RC-3095

1 reference

12 December 2020

Effect of bombesin, gastrin-releasing peptide (GRP)(14-27) and bombesin/GRP receptor antagonist RC-3095 on growth of nitrosamine-induced pancreatic cancers in hamsters

1 reference

12 December 2020

Dexamethasone and gastrin-releasing peptide receptors in human lung cells

1 reference

12 December 2020

Development and function of bombesin-like peptides and their receptors

1 reference

12 December 2020

Inhibitory effect of bombesin/gastrin-releasing peptide (GRP) antagonists RC-3950-II and RC-3095 on MCF-7 MIII human breast cancer xenografts in nude mice

1 reference

12 December 2020

A single in vivo administration of bombesin antagonist RC-3095 reduces the levels and mRNA expression of epidermal growth factor receptors in MXT mouse mammary cancers

1 reference

12 December 2020

The presence of receptors for bombesin/GRP and mRNA for three receptor subtypes in human ovarian epithelial cancers

1 reference

12 December 2020

Inhibition of growth of HT-29 human colon cancer xenografts in nude mice by treatment with bombesin/gastrin releasing peptide antagonist (RC-3095)

1 reference

12 December 2020

Antitumor activity of a monoclonal antibody directed against gastrin-releasing peptide in patients with small cell lung cancer.

1 reference

12 December 2020

Vasoactive intestinal polypeptide-, neurotensin-, substance P-, gastrin-releasing peptide-, calcitonin-, calcitonin gene related peptide-, and somatostatin-like immunoreactivities in human parathyroid glands

1 reference

12 December 2020